Mackay Shields LLC’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-16,600
Closed -$155K 1038
2021
Q1
$155K Buy
16,600
+2,000
+14% +$18.7K ﹤0.01% 1439
2020
Q4
$136K Sell
14,600
-55,800
-79% -$627K ﹤0.01% 1450
2020
Q3
$849K Sell
70,400
-44,300
-39% -$599K 0.01% 1063
2020
Q2
$1.55M Buy
114,700
+59,200
+107% +$821K 0.01% 876
2020
Q1
$572K Sell
55,500
-4,900
-8% -$67.1K 0.01% 1103
2019
Q4
$943K Buy
60,400
+26,100
+76% +$384K 0.01% 1080
2019
Q3
$470K Sell
34,300
-10,100
-23% -$123K ﹤0.01% 1274
2019
Q2
$576K Buy
+44,400
New +$528K ﹤0.01% 1249

Other funds holding LFVN

Mackay Shields LLC's LFVN Position: Q2 2021 in Review

Mackay Shields LLC sold out of LifeVantage (LFVN) in Q2 2021, closing a stake of 16,600 shares — an estimated $155K sold.

Mackay Shields LLC first reported a position in LFVN in Q2 2019 and held it in 8 quarters. The position peaked at $1.55M in Q2 2020. 76 funds tracked by Wall St. Rank hold LFVN as of Q2 2021.

  • Mackay Shields LLC reported no remaining LifeVantage position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 16,600 LifeVantage shares in Q2 2021, an estimated $155K.
  • Mackay Shields LLC first reported a position in LifeVantage in Q2 2019 and held it in 8 quarters.
  • Mackay Shields LLC's LifeVantage position peaked at $1.55M in Q2 2020.
  • 76 funds tracked by Wall St. Rank held LifeVantage as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.